< Back to previous page
Researcher
Steven Joniau
- Disciplines:Urology and nephrology
Affiliations
- Urogenital, Abdominal and Plastic Surgery (Division)
Member
From1 Jan 2019 → Today - Woman and Child (Division)
Member
From1 Apr 2013 → 31 Dec 2018
Projects
1 - 10 of 19
- Improvement of therapeutic management in patients with high-risk and oligorecurrent prostate cancerFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development of treatment intensification strategies for high-risk prostate cancer based on clinicopathological and molecular modeling, with the aim of delivering precision medicine to the individual patient.From1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The role of stromal components in urothelial cancerFrom4 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- New insights in the genomic architecture and treatment of high risk and oligometastatic prostate cancerFrom10 Sep 2021 → 30 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE)From24 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Classical and non-classical actions of androgens and their receptorFrom1 Oct 2019 → 30 Sep 2023Funding: IOF - technology concept exploration, BOF - projects
- Fellowship: Optimization patient treatment pathway by combining genotypic and phenotypic data.From17 Dec 2018 → 16 Dec 2019Funding: Private funding of national origin - undefined
- Novel insights in the definition and treatment of high risk and oligometastatic prostate cancerFrom1 Oct 2018 → 18 Nov 2022Funding: FWO fellowships
- Traveling the prostate cancer timeline in chase of treatment paradigms Can we cure the incurable?From1 Aug 2017 → 1 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Towards a better stratification of intermediate- and high-risk non-muscle-invasive bladder cancer patientsFrom1 Sep 2016 → 1 Sep 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
31 - 40 of 541
- Novel strategies in the management of high-risk and oligometastatic prostate cancer(2022)
Authors: Gaëtan Devos, Steven Joniau, Wouter Everaerts, Gert De Meerleer
- Treatment of patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) in Belgium: a real world data analysis(2022)
Authors: Steven Joniau
Pages: 897 - 905 - The Prevalence of Lower Limb and Genital Lymphedema after Prostate Cancer Treatment: A Systematic Review(2022)
Authors: Andries Clinckaert, Charlotte Van Calster, Inge Geraerts, Steven Joniau, Wouter Everaerts
- Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials(2022)
Authors: Steven Joniau, Gert De Meerleer
Pages: 3377 - + - Radical Prostatectomy or Radiotherapy in Oligometastatic Prostate Cancer: Is It Nearly Time To Call It a Draw?(2022)
Authors: Steven Joniau
Pages: 528 - 529 - Newly Diagnosed Oligometastatic Prostate Cancer: Current Controversies and Future Developments(2022)
Authors: Steven Joniau
Pages: 587 - 600 - Do we have enough evidence for approval of nadofaragene firadenovec?(2022)
Authors: Murat Akand, Frank Van der Aa, Steven Joniau
Pages: 646 - 647 - Simplified Semi-Quantification of [F-18]PSMA-1007 Uptake in Treatment-Naive Primary Prostate Cancer(2022)
Authors: Michel Koole, Wouter Everaerts, Steven Joniau, Christophe Deroose, Karolien Goffin
Pages: S505 - S506 - High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer(2022)
Authors: Steven Joniau
Pages: 484 - 490 - Another Step Towards the Acceptance of Metastasis-directed Therapy in Low-volume Metastatic Prostate Cancer(2022)
Authors: Gert De Meerleer, Kato Rans, Steven Joniau, Charlien Berghen
Pages: 428 - 429